SNORA40: A Unique Protein Involved in Neurotransmission and More

Target Name: SNORA40

NCBI ID: G677822

SNORA40

Other Name(s): SNORA40A | Small nucleolar RNA, H/ACA box 40 | ACA40 | small nucleolar RNA, H/ACA box 40

SNORA40: A Unique Protein Involved in Neurotransmission and More

SNORA40 (SNORA40A) is a protein that is expressed in various tissues and organs, including the brain, heart, liver, and pancreas. It is a member of the SNORA family of proteins, which are known for their role in cell signaling. SNORA40 is unique because it has a unique structure that allows it to interact with other proteins in the SNORA family and the neurotransmitter acetylcholine.

The SNORA family of proteins were identified through a combination of genetic and biochemical studies. The protein encoded by the SNORA40 gene is made up of 216 amino acids and has a calculated molecular mass of 24.5 kDa. It has a unique structure that includes a catalytic domain , a transmembrane region, and an intracellular loop. The catalytic domain is the region of the protein that contains the amino acids responsible for catalyzing chemical reactions, such as the metabolism of neurotransmitters. of the cell and interacts with other proteins in the SNORA family. The intracellular loop is the region of the protein that interacts with other proteins within the cell.

SNORA40 has been shown to play a role in various cellular processes, including neurotransmission, muscle contraction, and cell signaling. For example, studies have shown that SNORA40 interacts with the neurotransmitter acetylcholine and is involved in the regulation of neurotransmitter release. This suggests that SNORA40 may be a drug target or biomarker for various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression.

In addition to its role in neurotransmission, SNORA40 has also been shown to play a role in muscle function. Studies have shown that SNORA40 is involved in the regulation of muscle protein synthesis and that it interacts with the muscle protein myosin. This suggests that SNORA40 may be a drug target or biomarker for muscle-related disorders, including muscle weakness and myopathies.

SNORA40 has also been shown to play a role in cell signaling. Studies have shown that SNORA40 interacts with the protein Src, which is involved in cell signaling. This suggests that SNORA40 may be a drug target or biomarker for various cellular signaling pathways, including the regulation of cell growth, differentiation, and survival.

In conclusion, SNORA40 is a unique protein that has been shown to play a role in various cellular processes, including neurotransmission, muscle function, and cell signaling. Its unique structure and interactions with other proteins in the SNORA family and neurotransmitters make it a drug potential target or biomarker for various neurological and psychiatric disorders. Further research is needed to fully understand the role of SNORA40 in these processes and to develop effective treatments for these disorders.

Protein Name: Small Nucleolar RNA, H/ACA Box 40

The "SNORA40 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORA40 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets